NCT06603987 2025-11-19
Using CICS-1 and SPM-011 and ï¼»18Fï¼½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Stella Pharma Corporation
Phase 1/2 Enrolling by invitation
Stella Pharma Corporation
Massachusetts General Hospital
Moonshot Antibodies
Technical University of Munich
Region Stockholm
The Hospital for Sick Children
Rigshospitalet, Denmark